Enoxaparin Sodium is a low molecular weight heparin (LMWH) produced by the alkaline depolymerization of heparin benzyl ester derived from porcine intestinal mucosa. As a critical anticoagulant, it is utilized globally for the prevention of deep vein thrombosis (DVT), treatment of acute coronary syndromes, and management of pulmonary embolism. Our manufacturing process ensures a molecular weight distribution between 3,500 and 5,500 Daltons, providing the high anti-Xa/anti-IIa ratio essential for therapeutic efficacy.
The evolution of Enoxaparin production is shifting towards "Molecular Tailoring." By refining the depolymerization process, we are increasing the specificity of the anti-Xa activity while minimizing bleeding risks.
Utilizing blockchain-enabled tracking for the porcine mucosa supply chain, ensuring absolute compliance with African Swine Fever (ASF) safety protocols and origin verification.
Our Grade A cleanroom environment utilizes robotic aseptic filling technology, reducing human intervention and ensuring the lowest possible particulate levels in Enoxaparin injections.
Integrating AI-driven demand forecasting with lean manufacturing allows us to maintain a stable supply even during global logistics disruptions, supporting healthcare systems worldwide.
Jiangxi Serum Pharma Industries Co., Ltd. is a professional supplier of pharmaceutical and nutritional products in China. For nearly 10 years, we have been dedicated to exporting biological products, vaccines, Western medicines, raw materials, intermediates, medical consumables, food additives, and plant extracts, and have accumulated rich industry experience.
We provide full dossier support including CTD (Common Technical Document) for local MOH registration in Southeast Asia, MENA, and LATAM regions.
Customized supply chain solutions for national health departments and hospital groups to prevent shortages of essential anticoagulants.
Collaboration on "Pre-Mix" and "Co-Crystallization" technologies to enhance drug stability and bioavailability for emerging markets.
When sourcing Enoxaparin Sodium for international markets, procurement directors must evaluate more than just price. Quality assurance, regulatory agility, and volume stability are the pillars of a sustainable partnership.
Does the supplier hold a CEP/COS from EDQM? Are they FDA inspected? We ensure all Enoxaparin API meets these stringent benchmarks.
Our QC labs utilize specialized NMR spectroscopy and capillary electrophoresis to verify the complex sugar chains of Enoxaparin, ensuring bio-equivalence.
Porcine-derived products require high ethical and sanitary standards. We audit our source slaughterhouses to maintain a transparent and disease-free supply chain.
Customized formulation services for optimized nutrient and drug delivery.
Enhancing stability and solubility of complex active ingredients.
Next-generation probiotic and enzymatic production pathways.
FDA approval of Eli Lilly's Foundayo™ (orforglipron) marks a revolution in weight loss. We monitor these trends to align our metabolic health portfolio with market demands.
Analyzing the shift from shark-based to plant-derived squalene for sustainable vaccine adjuvants and nutritional products.
Why Dexamethasone remains a critical molecule in modern emergency medicine and its synergy with anticoagulant therapies.
